93 related articles for article (PubMed ID: 37338595)
1. ATM, ATR and DNA-PKcs kinases-the lessons from the mouse models: inhibition ≠ deletion.
Menolfi D; Zha S
Cell Biosci; 2020; 10():8. PubMed ID: 32015826
[TBL] [Abstract][Full Text] [Related]
2. Targeting ATR Pathway in Solid Tumors: Evidence of Improving Therapeutic Outcomes.
Mavroeidi D; Georganta A; Panagiotou E; Syrigos K; Souliotis VL
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38474014
[TBL] [Abstract][Full Text] [Related]
3. ATM: Functions of ATM Kinase and Its Relevance to Hereditary Tumors.
Ueno S; Sudo T; Hirasawa A
Int J Mol Sci; 2022 Jan; 23(1):. PubMed ID: 35008949
[TBL] [Abstract][Full Text] [Related]
4. The ATM signaling network in development and disease.
Stracker TH; Roig I; Knobel PA; Marjanović M
Front Genet; 2013; 4():37. PubMed ID: 23532176
[TBL] [Abstract][Full Text] [Related]
5. Tumor acidosis-induced DNA damage response and tetraploidy enhance sensitivity to ATM and ATR inhibitors.
Aubert L; Bastien E; Renoult O; Guilbaud C; Özkan K; Brusa D; Bouzin C; Richiardone E; Richard C; Boidot R; Léonard D; Corbet C; Feron O
EMBO Rep; 2024 Mar; 25(3):1469-1489. PubMed ID: 38366255
[TBL] [Abstract][Full Text] [Related]
6. Context matters: DNA virus infection reshapes DNA damage response pathways.
Johnson JR
Cell Syst; 2024 Apr; 15(4):305-306. PubMed ID: 38636456
[TBL] [Abstract][Full Text] [Related]
7. DNA damage response, a double-edged sword for vascular aging.
Zhang X; Zhao Q; Wang T; Long Q; Sun Y; Jiao L; Gullerova M
Ageing Res Rev; 2023 Dec; 92():102137. PubMed ID: 38007046
[TBL] [Abstract][Full Text] [Related]
8. Pathogenic variants in human DNA damage repair genes mostly arose in recent human history.
Zhao B; Li J; Sinha S; Qin Z; Kou SH; Xiao F; Lei H; Chen T; Cao W; Ding X; Wang SM
BMC Cancer; 2024 Apr; 24(1):415. PubMed ID: 38575974
[TBL] [Abstract][Full Text] [Related]
9. Association of genetic variants in ATR-CHEK1 and ATM-CHEK2 pathway genes with risk of colorectal cancer in a Chinese population.
Wang S; Zhang Y; Chen M; Wang Y; Feng Y; Xu Z; Zhang D; Sun Y; Fu Z
Oncotarget; 2018 Jun; 9(42):26616-26624. PubMed ID: 29928473
[TBL] [Abstract][Full Text] [Related]
10. Progress towards a clinically-successful ATR inhibitor for cancer therapy.
Barnieh FM; Loadman PM; Falconer RA
Curr Res Pharmacol Drug Discov; 2021; 2():100017. PubMed ID: 34909652
[TBL] [Abstract][Full Text] [Related]
11. Targeting DNA repair pathway in cancer: Mechanisms and clinical application.
Wang M; Chen S; Ao D
MedComm (2020); 2021 Dec; 2(4):654-691. PubMed ID: 34977872
[TBL] [Abstract][Full Text] [Related]
12. Genotoxicity associated with retroviral CAR transduction of ATM-deficient T cells.
Rozenbaum M; Fluss R; Marcu-Malina V; Sarouk I; Meir A; Elitzur S; Zinger T; Jacob-Hirsch J; Glick Saar E; Rechavi G; Jacoby E
Blood Cancer Discov; 2024 May; ():. PubMed ID: 38747501
[TBL] [Abstract][Full Text] [Related]
13. Depletion of ATR selectively sensitizes ATM-deficient human mammary epithelial cells to ionizing radiation and DNA-damaging agents.
Cui Y; Palii SS; Innes CL; Paules RS
Cell Cycle; 2014; 13(22):3541-50. PubMed ID: 25483091
[TBL] [Abstract][Full Text] [Related]
14. Investigation of switch from ATM to ATR signaling at the sites of DNA damage induced by low and high LET radiation.
Saha J; Wang M; Cucinotta FA
DNA Repair (Amst); 2013 Dec; 12(12):1143-51. PubMed ID: 24238855
[TBL] [Abstract][Full Text] [Related]
15. The Adenovirus E4orf4 Protein Provides a Novel Mechanism for Inhibition of the DNA Damage Response.
Brestovitsky A; Nebenzahl-Sharon K; Kechker P; Sharf R; Kleinberger T
PLoS Pathog; 2016 Feb; 12(2):e1005420. PubMed ID: 26867009
[TBL] [Abstract][Full Text] [Related]
16. DNA damage response and hematological malignancy.
Takagi M
Int J Hematol; 2017 Sep; 106(3):345-356. PubMed ID: 28374143
[TBL] [Abstract][Full Text] [Related]
17. Targeting ATM and ATR for cancer therapeutics: Inhibitors in clinic.
Priya B; Ravi S; Kirubakaran S
Drug Discov Today; 2023 Aug; 28(8):103662. PubMed ID: 37302542
[TBL] [Abstract][Full Text] [Related]
18. Expression variations of DNA damage response genes ATM and ATR in blood cancer patients.
Parvez A; Mahjabeen I; Mehmood A; Khan AU; Nisar A; Kayani MA
Mol Genet Genomics; 2023 Sep; 298(5):1173-1183. PubMed ID: 37338595
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
